Previous 10 | Next 10 |
BELGRADE, Mont., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Mark Schallenberger as Chief Operations Officer, effec...
Company Sponsors Donate Life Float at Rose Parade for the Ninth Year BELGRADE, Mont., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, honors...
Xtant Medical Holdings, Inc. (XTNT) Q3 2022 Results Conference Call November 03, 2022 09:00 AM ET Company Participants Matt Steinberg - IR, FINN Partners Sean Browne - President and Chief Executive Officer Scott Niels - Chief Financial Officer Presentation ...
Xtant Medical press release ( NYSE: XTNT ): Q3 GAAP EPS of -$0.03. Revenue of $14.46M (+4.8% Y/Y). For further details see: Xtant Medical GAAP EPS of -$0.03, revenue of $14.46M
BELGRADE, Mont., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended Septembe...
BELGRADE, Mont., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter en...
BELGRADE, Mont., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the second and final tranche of its previously annou...
BELGRADE, Mont., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the first tranche of its previously announced privat...
Xtant Medical Holdings ( NYSE: XTNT ) has entered into a securities purchase agreement to sell Xtant common stock and warrants to a select group of accredited investors led by Stavros Vizirgianakis, a successful biotechnology executive and investor. Subject to the terms, t...
Upon completion of first closing, Stavros Vizirgianakis to become Non-Executive Chairman BELGRADE, Mont., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spin...
News, Short Squeeze, Breakout and More Instantly...
Xtant Medical Holdings Inc. Company Name:
XTNT Stock Symbol:
NYSE Market:
Xtant Medical Holdings Inc. Website:
BELGRADE, MT / ACCESSWIRE / May 22, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief...
Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT / ACCESSWIRE / May 15, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial a...
BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2...